The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia

OBJECTIVE To reveal the influence of preoperative factors on the prognosis of patients undergoing percutaneous transluminal angioplasty (PTA) for critical limb ischemia (CLI). RESEACH DESIGN AND METHODS We recruited 278 Japanese patients who underwent PTA for CLI between 2003 and 2009. The outcome measures were mortality and major amputation. Cox proportional hazards regression analyses were performed. RESULTS The prevalence of diabetes was 71%, and A1C was 7.0 ± 1.4%. The follow-up period was 90 ± 72 weeks, and 48 patients underwent major amputations and 89 died. The presence of diabetes in the whole population and A1C level in the diabetic population had no influence on morality; rather, mortality was associated with age (P = 0.007), impaired activities of daily living (P < 0.001), hemodialysis (P < 0.001), and albumin level (P = 0.010). In contrast, the presence of diabetes and A1C level had significant association with major amputation (P = 0.012 and P = 0.007, respectively). The quartile analysis showed that diabetic subjects with an A1C ≥6.8%, but not <6.8%, had a significantly higher risk of major amputation than nondiabetic subjects. The adjusted hazard ratio of diabetes with A1C ≥6.8% was 2.907 (95% CI 1.606–5.264) (P < 0.001). CONCLUSIONS Diabetes with poor glycemic control is associated with major amputation, but not mortality, in CLI patients undergoing PTA. Prognostic indicators seem somewhat different between survival and limb salvage in the population.

• Publication year

  2010

• Venue

  Diabetes Care

• Publication date

  2010-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc10-0939PMID 20843974PMCID 2992184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional status as a prognostic factor for primary revascularization for critical limb ischemia.

  2010cited by this paper
• Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis.

  2010cited by this paper
• Serum albumin and total lymphocyte count as predictors of outcome in hip fractures.

  2010cited by this paper
• The Relationship between Hemoglobin A1c Values and Healing Time for Lower Extremity Ulcers in Individuals with Diabetes

  2009cited by this paper
• Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia

  2009cited by this paper
• Advanced glycoxidation products and impaired diabetic wound healing

  2009cited by this paper
• Bypass surgery for chronic lower limb ischaemia.

  2008cited by this paper
• The biology of chronic foot ulcers in persons with diabetes

  2008cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome

  2007cited by this paper
• Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.

  2007cited by this paper
• Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects

  2005cited by this paper
• Wound healing and its impairment in the diabetic foot.

  2005cited by this paper
• Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.

  2005cited by this paper
• Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia.

  2004cited by this paper
• Quantifying the risk of infectious diseases for people with diabetes.

  2003cited by this paper
• A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia.

  2003cited by this paper
• Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects

  2002cited by this paper
• Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

  2000cited by this paper
• Presidential address: a team for the 21st century: the vascular center.

  2000cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• The Management and Outcome of Critical Limb Ischaemia in Diabetic Patients: Results of a National Survey

  1996cited by this paper

• 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.

  2026cites this paper
• 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.

  2026cites this paper
• Development and Validation of Overall Survival and Amputation-Free Survival Prediction Models for Patients with Peripheral Arterial Disease Who underwent Endovascular Therapy.

  2025cites this paper
• 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

  2025cites this paper
• Diabetes mellitus and peripheral artery disease

  2025cites this paper
• 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• Impact of High Lipoprotein(a) Levels on Delayed Wound Healing in Patients With Chronic Limb-Threatening Ischemia After Peripheral Endovascular Therapy.

  2024cites this paper
• Association of Undernutrition With Mortality and Amputation Outcomes in Chronic Limb Threatening Ischaemia: A Systematic Review.

  2024cites this paper
• 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2024cites this paper
• 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

  2024cites this paper
• Revascularization Outcomes Stratified by Glycemic Control in Patients with Diabetes Mellitus and Chronic Limb-Threatening Ischemia.

  2023cites this paper
• Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia

  2023cites this paper
• Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

  2023cites this paper
• 10-Year clinical outcomes of hemodialysis patients with peripheral arterial disease due to infrainguinal disease undergoing endovascular therapy

  2022cites this paper
• Effect of Comorbidities on Outcomes of Infrapopliteal Angioplasty in Patients with Chronic Limb-Threatening Ischemia

  2022cites this paper
• Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study

  2021cites this paper
• Comprehensive Assessment of Current Management Strategies for Patients With Diabetes and Chronic Limb-Threatening Ischemia

  2021cites this paper
• Diabetes Mellitus and Lower Extremity Peripheral Artery Disease

  2021cites this paper
• Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities

  2021cites this paper
• Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies

  2021cites this paper
• Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients

  2021cites this paper
• Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients.

  2021cites this paper
• The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis.

  2020cites this paper
• Diabetes mellitus: an important risk factor for peripheral vascular disease

  2020influential citation
• Impact of Diabetes Mellitus on Critical Limb Ischemia With Below the Knee Disease: Japan Below-the-Knee Artery Treatment Subanalysis

  2020cites this paper
• When diabetes encounters chronic limb-threatening ischemia: Sweet life with a foot left behind?

  2020cites this paper
• The interrelationship between diabetes mellitus and peripheral arterial disease - a systematic review.

  2020cites this paper
• A Systematic Review and Meta-analysis of Gender Differences in Long-term Mortality and Cardiovascular Events in Peripheral Artery Disease.

  2020cites this paper
• Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)

  2020cites this paper
• Heterogeneity of Age and Its Associated Features in Patients with Critical Limb Ischemia

  2020cites this paper
• Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort

  2020influential citation
• Education of Patients with Diabetes Mellitus and Peripheral Artery Disease

  2019cites this paper
• Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.

  2019cites this paper
• Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.

  2019cites this paper
• ESC/ESVS-Guidelines 2017 zur Diagnose und Behandlung der peripheren arteriellen Verschlusskrankheit // ESC-ESCS-Guidelines 2017 for diagnosis and treatment of peripheral arterial occlusive disease

  2019cites this paper
• Pharmacological Therapy of Peripheral Artery Disease in Patients with Diabetes Mellitus: Cardiovascular Risk Factor Management

  2019cites this paper
• The position of Polish experts on conservative management in patients with artery diseases of lower limbs

  2019cites this paper
• TITLE: Exercise rehabilitation for patients with critical limb ischemia peripheral arterial disease after revascularization: a single center pilot randomized controlled trial assessing quality of life and functional capacity after a 12-week rehabilitation program compared with best medical therapy

  2019cites this paper
• ESC/ESVS-Guidelines 2017 zur Diagnose und Behandlung der peripheren arteriellen Verschlusskrankheit // ESC-ESCS-Guidelines 2017 for diagnosis and treatment of peripheral arterial occlusive disease

  2019cites this paper
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

  2019cites this paper
• Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases

  2019cites this paper
• Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia.

  2019cites this paper
• Stanowisko polskich ekspertów dotyczące leczenia zachowawczego u pacjentów z chorobą tętnic kończyn dolnych

  2019cites this paper
• The role of age in determining the effects of lipo-PGE1 infusion on immediate arterial maximal flow velocity in patients with diabetes undergoing free flap surgery for lower extremity reconstruction: A prospective observational study.

  2019cites this paper
• Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

  2018cites this paper
• High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization

  2018cites this paper
• Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS)

  2018cites this paper
• Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say?

  2018cites this paper
• 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b

  2018cites this paper
• Medical and lifestyle management of peripheral arterial disease.

  2018cites this paper
• Chronic Limb‐Threatening Ischemia

  2018cites this paper
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2017cites this paper
• 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary

  2017cites this paper
• Evaluation of paramalleolar and inframalleolar bypasses in dialysis- and nondialysis-dependent patients with critical limb ischemia.

  2017cites this paper
• Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda

  2017cites this paper
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2017cites this paper
• Medical Therapy of Peripheral Artery Disease

  2017cites this paper
• Endocrine Considerations in Critical Limb Ischemia

  2017cites this paper
• Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria.

  2016cites this paper
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

  2016cites this paper
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary

  2016cites this paper
• Three‐year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss

  2015cites this paper
• An Elevated Glycemic Gap is Associated With Adverse Outcomes in Diabetic Patients With Community-Acquired Pneumonia

  2015cites this paper
• The Outcome of Percutaneous Transluminal Angioplasty in Patients with CriticalLimb Ischemia and how Diabetes May Influence this Outcome

  2015cites this paper
• Clinical characteristics of patients with Rutherford category IV, compared with V and VI

  2015cites this paper
• Clinical efficacy of infrapopliteal endovascular procedures for hemodialysis patients with critical limb ischemia.

  2015cites this paper
• Elevated plasma B-type natriuretic peptide concentration and resistive index, but not decreased aortic distensibility, associate with impaired blood flow at popliteal artery in type 2 diabetic patients.

  2015cites this paper
• Prognostic Factors in Hemodialysis Patients Undergoing Endovascular Treatment for Critical Limb Ischemia due to Isolated Below-the-Knee Disease.

  2015cites this paper
• Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty

  2014cites this paper
• Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia.

  2014cites this paper
• Wound Healing in Peripheral Arterial Disease:Current and Future Therapy

  2014cites this paper
• Surgical reconstruction versus peripheral intervention in patients with critical limb ischemia – a prospective multicenter registry in Japan: The SPINACH study design and rationale

  2014cites this paper
• Meta‐analysis of contemporary short‐ and long‐term mortality rates in patients diagnosed with critical leg ischaemia

  2013cites this paper
• Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions.

  2013cites this paper
• An Elevated Gap between Admission and A1C-Derived Average Glucose Levels Is Associated with Adverse Outcomes in Diabetic Patients with Pyogenic Liver Abscess

  2013cites this paper
• The amputation and mortality rates of diabetic patients with critical limb ischemia: A nationwide population-based follow-up study in Taiwan

  2013cites this paper
• Worse limb prognosis for indirect versus direct endovascular revascularization only in patients with critical limb ischemia complicated with wound infection and diabetes mellitus.

  2013cites this paper
• Type 2 diabetes and atherosclerosis: focusing on metabolic syndrome

  2013cites this paper
• Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.

  2012cites this paper
• Pharmacological interventions on critical limb ischemia in diabetic patients.

  2012cites this paper
• Angiographic restenosis and its clinical impact after infrapopliteal angioplasty.

  2012cites this paper
• Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions.

  2012cites this paper
• Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia.

  2011cites this paper
• No association of diabetic duration or insulin use with the prognosis of critical limb ischemia after endovascular therapy.

  2011cites this paper
• Sage Open Medicine

  year unknowncites this paper
• Wound Healing in Peripheral Arterial Disease: Current and Future Wound Healing in Peripheral Arterial Disease: Current and Future Therapy Therapy

  year unknowncites this paper